Evolent Health (EVH) Change in Accured Expenses (2015 - 2026)

Evolent Health's Change in Accured Expenses history runs 12 years deep, the most recent figure standing at -$21.0 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 1055.9% year-over-year to -$21.0 million in Q1 2026; TTM through Mar 2026 was -$5.9 million, a 212.0% decrease from a year earlier, with the FY2025 full-year figure at $17.3 million, up 171.36% from the prior year.
• Change in Accured Expenses eased to -$21.0 million in Q1 2026 per EVH's latest filing, from -$4.4 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $32.5 million in Q4 2023 and bottomed at -$41.8 million in Q4 2024.
• The 5-year median for Change in Accured Expenses is $2.3 million (2025), against an average of -$224235.3.
• Across the five-year window, Change in Accured Expenses surged 205.35% in 2024 and slumped 1055.9% in 2026, its largest moves.
• Year by year, Change in Accured Expenses stood at $14.9 million in 2022, then soared by 117.88% to $32.5 million in 2023, then sank by 228.92% to -$41.8 million in 2024, then soared by 89.5% to -$4.4 million in 2025, then sank by 377.62% to -$21.0 million in 2026.
• Per Business Quant, the three latest EVH Change in Accured Expenses figures stand at -$21.0 million (Q1 2026), -$4.4 million (Q4 2025), and $17.1 million (Q3 2025).